Please provide your email address to receive an email when new articles are posted on . BIG FLATS, N.Y. — X-GEN Pharmaceuticals will begin marketing acetazolamide for injection, the equivalent of ...
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Acetazolamide Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The Global Acetazolamide Market is estimated to be USD ...
J Glaucoma. 2015;24(4):E31-e33. In our case, the patient presented with typical features of hypophosphatemia including general weakness, hypercapnic respiratory failure, arrhythmias, and cardiac ...
To determine whether the 1-day postoperative intraocular pressure (IOP) check following routine uncomplicated phacoemulsification is necessary in patients with pre-existing glaucoma and ocular ...
Background This is a 63-year-old female hiker with normal corrected vision followed status post emergent surgery secondary to bilateral acute angle closure glaucoma (AACG). She was started on ...
The Department of Pharmaceuticals (DoP) has rejected the review application of Sun Pharma Laboratories filed against the retail price fixed by the National Pharmaceutical Pricing Authority’s (NPPA) ...
Please provide your email address to receive an email when new articles are posted on . Studies show that lowering intraocular pressure (IOP) reduces the rate of progression of glaucoma. First-line ...
BARCELONA -- The addition of IV acetazolamide to loop diuretic therapy led to a greater incidence of successful early decongestion in patients with acute decompensated heart failure (HF), according to ...
Acetazolamide-related hypophosphatemia leading to cardiac arrest is extremely rare. Herein we report a 78-year-old female glaucoma patient who developed general weakness and acute respiratory failure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback